BYAH logo

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) ein Consumer Cyclical-Unternehmen mit einer Bewertung von 0. Die Aktie erzielt 50/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.

Zuletzt analysiert: 17. März 2026
50/100 KI-Bewertung

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Konsumgueeter-Geschaeftsueberblick

CEOXiaoqiu Zhang
Mitarbeiter31
HauptsitzWuxi, CN
IPO-Jahr2025

Park Ha Biological Technology Co., Ltd. is a China-based investment holding company specializing in the development and distribution of skincare products under the “Park Ha” brand. The company operates in the competitive personal care market, utilizing direct sales and franchise models within the People's Republic of China.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Park Ha Biological Technology Co., Ltd. operates in the attractive Chinese skincare market, evidenced by a high gross margin of 90.6%. However, the company's negative profit margin of -965.0% raises concerns about operational efficiency and cost management. With a market capitalization of $0.00B and a negative P/E ratio of -0.03, the company's valuation is challenging. Growth catalysts include expanding its franchise network and enhancing its direct sales capabilities. Key risks include intense competition in the skincare market and the company's current lack of profitability. Monitoring the company's ability to improve its bottom line and effectively manage its operational costs is crucial for assessing its long-term viability.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Gross Margin of 90.6% indicates strong pricing power and efficient cost of goods sold.
  • Negative Profit Margin of -965.0% signals significant operational inefficiencies or high operating expenses.
  • Market Cap of $0.00B reflects the company's small size and potential illiquidity.
  • P/E Ratio of -0.03 indicates the company is currently not profitable.
  • Beta of -3.94 suggests the stock is significantly less volatile than the market, but may also reflect a lack of trading activity.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Established brand presence in the Chinese skincare market.
  • Franchise network provides a scalable distribution model.
  • High gross margin indicates strong pricing power.
  • Focus on a specific niche within the consumer cyclical sector.

Schwaechen

  • Negative profit margin indicates operational inefficiencies.
  • Small market capitalization limits access to capital.
  • Limited geographic diversification, relying solely on the Chinese market.
  • High beta suggests potential volatility.

Katalysatoren

  • Upcoming: Expansion of the franchise network into new regions within China, targeting Tier 2 and Tier 3 cities by Q4 2026.
  • Ongoing: Development and launch of new skincare products catering to specific consumer needs and preferences, with a focus on natural and organic ingredients.
  • Ongoing: Implementation of targeted marketing campaigns and social media strategies to enhance brand awareness and drive customer acquisition.

Risiken

  • Potential: Intense competition from established domestic and international brands, potentially impacting market share and profitability.
  • Potential: Changes in consumer preferences and trends in the skincare market, requiring continuous innovation and adaptation.
  • Ongoing: Regulatory changes and compliance requirements in China, potentially increasing operational costs and complexity.
  • Potential: Economic downturns affecting consumer spending on discretionary items, potentially reducing demand for skincare products.

Wachstumschancen

  • Expanding Franchise Network: Park Ha can grow by expanding its franchise network across China, particularly in Tier 2 and Tier 3 cities where demand for skincare products is increasing. The market size for skincare products in these regions is estimated to reach $50 billion by 2028. By offering attractive franchise terms and providing comprehensive support to franchisees, Park Ha can accelerate its market penetration and increase brand visibility. This expansion can be achieved within the next 3-5 years.
  • Enhancing Direct Sales Capabilities: Investing in its direct sales channels, including online platforms and direct marketing initiatives, can enable Park Ha to reach a broader customer base and improve customer engagement. The e-commerce market for skincare products in China is projected to grow to $80 billion by 2027. By leveraging data analytics and personalized marketing, Park Ha can optimize its direct sales efforts and drive revenue growth. This initiative can be implemented within the next 2 years.
  • Product Innovation and Diversification: Developing new and innovative skincare products that cater to specific consumer needs and preferences can help Park Ha differentiate itself from competitors and capture a larger market share. The demand for specialized skincare products, such as anti-aging and acne treatment solutions, is growing rapidly. By investing in research and development and collaborating with leading dermatologists, Park Ha can launch new products that address unmet consumer needs. This can be an ongoing effort with new products released every 12-18 months.
  • Strengthening Brand Awareness: Implementing targeted marketing campaigns and leveraging social media platforms to enhance brand awareness and build brand loyalty can drive customer acquisition and retention. The use of Key Opinion Leaders (KOLs) and influencers in the beauty industry is highly effective in China. By partnering with popular KOLs and creating engaging content, Park Ha can increase its brand visibility and attract new customers. This is an ongoing opportunity with continuous marketing efforts.
  • Strategic Partnerships and Collaborations: Forming strategic partnerships with complementary businesses, such as beauty salons and spas, can expand Park Ha's distribution channels and reach new customer segments. Collaborating with these businesses can provide Park Ha with access to a wider customer base and enhance its brand image. This initiative can be pursued within the next 1-3 years, focusing on building mutually beneficial relationships.

Chancen

  • Expanding the franchise network to new regions within China.
  • Developing new and innovative skincare products.
  • Leveraging e-commerce and social media to enhance direct sales.
  • Forming strategic partnerships with complementary businesses.

Risiken

  • Intense competition from established domestic and international brands.
  • Changing consumer preferences and trends in the skincare market.
  • Regulatory changes and compliance requirements in China.
  • Economic downturns affecting consumer spending on discretionary items.

Wettbewerbsvorteile

  • Brand Recognition: The “Park Ha” brand may have some level of recognition within the Chinese market, providing a competitive edge.
  • Franchise Network: The established franchise network provides a distribution advantage and recurring revenue stream.
  • Proprietary Formulations: The company's skincare products may contain unique formulations that differentiate them from competitors.

Ueber BYAH

Park Ha Biological Technology Co., Ltd. is an investment holding company that operates in the consumer cyclical sector, specifically within the personal products and services industry. The company focuses on the development, distribution, and sales of skincare products under its proprietary “Park Ha” brand. Headquartered in Wuxi, China, Park Ha conducts its business through subsidiaries that engage in direct product sales and franchise operations. The company's business model emphasizes a direct-to-consumer approach, leveraging franchise networks to expand its market reach across the People's Republic of China. Park Ha aims to cater to the growing demand for skincare products in the Chinese market by offering a range of products designed to meet diverse consumer needs. While the company's history and specific founding details are not provided, its current strategy revolves around strengthening its brand presence and optimizing its distribution channels to enhance profitability and market share in the competitive skincare industry. The company currently employs 31 individuals.

Was das Unternehmen tut

  • Develops skincare products under the “Park Ha” brand.
  • Operates as an investment holding company.
  • Engages in direct product sales through its subsidiaries.
  • Provides franchise services to expand its distribution network.
  • Focuses on the Chinese skincare market.
  • Manages a portfolio of skincare products targeting various consumer needs.

Geschaeftsmodell

  • Develops and markets skincare products under its own brand.
  • Generates revenue through direct sales of products to consumers.
  • Expands market reach through a franchise model, earning fees and royalties from franchisees.

Branchenkontext

The personal products and services industry is characterized by intense competition, evolving consumer preferences, and a constant need for innovation. The Chinese skincare market, in particular, is experiencing substantial growth, driven by increasing disposable incomes and a rising awareness of skincare products. Park Ha Biological Technology Co., Ltd. operates in this dynamic environment, competing with both domestic and international brands. Key trends include the growing popularity of e-commerce, the demand for natural and organic products, and the increasing influence of social media marketing. Companies like AZI, BTBD, CENN, CGTL, and DSS represent some of the competitors in this space, each vying for market share through different product offerings and distribution strategies.

Wichtige Kunden

  • Consumers in the People's Republic of China seeking skincare products.
  • Franchisees who operate Park Ha branded stores and sell products.
  • Customers seeking a range of skincare solutions for different skin types and concerns.
KI-Zuversicht: 69% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer BYAH.

Kursziele

Wall-Street-Kurszielanalyse fuer BYAH.

MoonshotScore

50/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von BYAH auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Xiaoqiu Zhang

CEO

Xiaoqiu Zhang serves as the CEO of Park Ha Biological Technology Co., Ltd., overseeing the company's operations and strategic direction. While specific details regarding Zhang's educational background and previous roles are not available, their leadership is focused on driving growth and profitability within the competitive skincare market in China. Zhang is responsible for managing the company's 31 employees and ensuring the effective execution of its business strategy.

Erfolgsbilanz: As CEO, Xiaoqiu Zhang is responsible for guiding Park Ha Biological Technology Co., Ltd. through the challenges and opportunities of the Chinese skincare market. Specific achievements and milestones under Zhang's leadership are not detailed in the provided information. However, their focus is likely on expanding the company's franchise network, enhancing its direct sales capabilities, and improving its overall financial performance.

Haeufige Fragen zu BYAH

What are the key factors to evaluate for BYAH?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) currently holds an AI score of 50/100, indicating moderate score. Key strength: Established brand presence in the Chinese skincare market.. Primary risk to monitor: Potential: Intense competition from established domestic and international brands, potentially impacting market share and profitability.. This is not financial advice.

How frequently does BYAH data refresh on this page?

BYAH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven BYAH's recent stock price performance?

Recent price movement in Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brand presence in the Chinese skincare market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider BYAH overvalued or undervalued right now?

Determining whether Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying BYAH?

Before investing in Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding BYAH to a portfolio?

Potential reasons to consider Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Established brand presence in the Chinese skincare market.. Additionally: Franchise network provides a scalable distribution model.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of BYAH?

Yes, most major brokerages offer fractional shares of Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track BYAH's earnings and financial reports?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for BYAH earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Financial data is limited, and the absence of analyst coverage introduces uncertainty.
  • The company's future performance is subject to various risks and uncertainties, including competition, regulatory changes, and economic conditions.
Datenquellen

Popular Stocks